In this episode, we hear from, Rich Brancaccio, Chief Innovation Officer of Revibe Technologies, and Lindsay Ayearst, Chief Scientific Officer of Revibe Technologies.
In their own words, Revibe is a digital therapeutics company fusing behavioral science with technology and currently developing a new digital therapy for ADHD.

In this episode, we cover:

Founding story and funding milestones

Child and caregiver experience using Revibe

Quantifying attention & capturing focus data

Evidence generation journey & clinical endpoints

The ADHD market choice to focus on adolescent ADHD

Lessons learned from the first wave of similar products and companies

OTC vs PDT


Guest Links and Resources:

Connect with Lindsay Ayearst on LinkedIn


Connect with Rich Brancaccio on LinkedIn


Visit www.revibetech.com



Host Links:

Connect with Eugene Borukhovich: Twitter | LinkedIn


Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn


Connect with YourCoach.health: Website | Twitter


Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App


HealthXL: Website | Twitter | Join an Event




Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:
> Presenting Partner: Amalgam Rx
> Contributing Partners and Sponsors: LSI | Bayer G4A | Lindus Health

Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram

Ver todos los episodios